FRX

Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treatment of opioid addiction with pain management; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations, namely, antidepressants; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations in the form of topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves for treating chemical imbalances, inflammation, epilepsy, depression, cancer, and opioid addiction with pain management; all of the foregoing containing or solely derived from CBD derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; anti-epileptic pharmaceutical preparations containing no CBD

Dispensing of pharmaceuticals containing or solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis; Dispensing of pharmaceuticals containing no CBD